Dr. Thomas Shrader

BTIG Research

Recent Articles about Verona Pharma Plc

Pharma Stock Focuses on Successful Ensifentrine Launch 05/15/2024

Verona Pharma Plc. is well positioned to launch its ensifentrine into the substantial market of nearly 9 million COPD patients, according to a BTIG Research note.